Technetium Tc 99m sulfur colloid injection - Pharmalucence
Alternative Names: AN-Sulfur Colloid - Pharmalucence; Kit for the preparation of Technetium Tc 99m sulfur colloid injection (SCI) - Pharmalucence; Tc 99m sulfur colloid kitLatest Information Update: 24 Oct 2021
At a glance
- Originator Pharmalucence
- Class Imaging agents; Inorganic sulfur compounds; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; Malignant melanoma
Most Recent Events
- 16 Aug 2012 Launched for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
- 16 Aug 2012 Registered for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
- 16 Aug 2012 Technetium Tc 99m sulfur colloid injection - Pharmalucence receives Orphan Drug status for Malignant melanoma (localisation of lymph nodes) in USA